Loading organizations...
Platform treating urinary incontinence and skeletal muscle degradation.
MUVON Therapeutics has raised $15.0M across 1 funding round.
MUVON Therapeutics has raised $15.0M in total across 1 funding round.
MUVON Therapeutics has raised $15.0M in total across 1 funding round.
MUVON Therapeutics's investors include Lichtsteiner Foundation, University of Zurich, Wyss Zurich.
MUVON Therapeutics has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series A in May 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 31, 2021 | $15.0M Series A | Lichtsteiner Foundation, University of Zurich, Wyss Zurich |